EMGenisys

Embryo health analysis at your fingertips

EMGenisys has $1.5M in recorded funding across 1 round.

Business Model
B2B
Total Funding
$1.5M
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

EmGenisys improves embryo transfer pregnancy outcomes with objective, data-driven embryo analysis, giving producers embryo health analysis at their fingertips. Using proven technologies, the company selects healthy embryos for transfer, which increases the productivity of animals and offers benefits at both the producer level and industry at large. Selecting healthy, viable embryos means lower stress factors for livestock, an increased bottom line for producers, and progress toward maximized efficiency.

Summary

EMGenisys is an Agtech company. It has raised $1.5M in total across 1 round. Investors include Tall Grass Ventures.

Funding History

SeedSeed Round
$1.5M

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EMGenisys on Indexed.vc
<a href="https://indexed.vc/companies/emgenisys"><img src="https://indexed.vc/api/badge/company/emgenisys" alt="EMGenisys on Indexed.vc" width="260" height="76" /></a>